The exact prevalence of chronic
abdominal pain in children is not known. It appears to account for 2% to 4% all of pediatric office visits ( ). One study suggested that 13% of middle school students and 17% of high school students experience weekly 1 abdominal pain ( ). In the latter study, it was also noted that approximately 8% of all students had seen a physician for evaluation of 2 abdominal pain in the previous year. Quality of life in adult patients with chronic abdominal pain is substantially poorer than that of the general population ( ). The economic cost related to this condition in children is not known but is likely to be substantial, considering that expenses associated with 3 irritable bowel syndrome (IBS) in adults have been estimated to be $8 billion to $30 billion per year ( ). The long-term outcome of this condition has not been determined, but preliminary data indicate that young adults with a history of recurrent 4-6 abdominal pain that began in childhood who are treated by a subspecialist are significantly more likely than their peers without recurrent abdominal pain to have lifelong psychiatric problems and migraine headaches ( ). Despite the high prevalence and effects of this condition, no evidence-based guidelines for its evaluation and treatment exist. 7
With this background in mind, the American Academy of Pediatrics and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition established a subcommittee charged with developing evidence-based guidelines for the evaluation and treatment of chronic
abdominal pain in children. A major problem in reviewing the literature arose in defining criteria for recurrent or chronic abdominal pain. For many years, the term “recurrent abdominal pain” has been used to describe all cases without an organic etiology. It was first introduced in the pediatric literature by Apley and Naish ( ) in the late 1950s during an era when some organic gastrointestinal disorders had not been fully appreciated. Children were considered to have recurrent 8 abdominal pain if they had experienced at least three bouts of pain severe enough to affect activities over a period of at least 3 months. This definition had initially constituted the entry criteria for their descriptive studies, but recurrent abdominal pain later became a term used clinically to describe all children with abdominal pain without an organic etiology. It is now agreed that recurrent abdominal pain is a description rather than a diagnosis. Recurrent abdominal pain, as a case definition, includes children with a variety of functional gastrointestinal disorders causing abdominal pain, such as nonulcer dyspepsia, IBS or abdominal migraine. It may also include children with organic disease. In this document, we will avoid use of the term “recurrent abdominal pain” whenever possible to lessen the confusion that the term engenders. Table 1 summarizes terms currently used to describe long-lasting constant or intermittent childhood abdominal pain. TABLE 1:
Currently Used Definitions to Describe Childhood
The preponderance of the available pediatric literature on this subject is still based on the Apley and Naish criteria (
). Thus, evidence was sought in articles that were selected based on the presence of Apley and Naish criteria as entry criteria unless the subcommittee felt that other strong qualities (for example, large epidemiologic study or double-blind randomized controlled trial [RCT]) justified their evaluation and inclusion as part of the evidence. This meant that some articles including children with 8 abdominal pain of less than 3 months' duration were excluded from consideration.
After a careful evaluation of the published literature, no evidence-based procedural algorithm could be produced; instead, questions of interest to clinicians were posed and clinical guidance was generated linked to the standard clinical approach of history, physical examination, diagnostic testing, and treatment. The document is organized in the following manner: 1) the methodology used to review the evidence and generate the statements is described; 2) questions are answered regarding subgroups of disorders, the role of diagnostic evaluation (history, laboratory tests, radiologic and invasive techniques and psychosocial evaluation) and the efficacy of pharmacological, behavioral and surgical interventions; and 3) a summary of the quality of the evidence is provided (
Appendix A). METHODOLOGY
The guideline development process of Woolf et al. (
) was used, with a subcommittee of experts and community physicians guiding the work of the methodologist (HPL) to assemble the evidence, reviewing the results of the methodologist, and using the Nominal Group Technique ( 9 ) to arrive at conclusions based on the evidence. 10
After initial discussions, 15 questions were defined and collapsed into the eight questions in this review. An initial search (
Table 2) was performed on PubMed ( /entrez/query.fcgi?db=PubMed) on October 27, 2000, searching for “ www.ncbi.nlm.nih.gov abdominal pain” in the broadest possible way but limited to pediatric studies; 1498 titles were retrieved. This search was repeated on June 19, 2002, providing another 158 references, for a total of 1656. TABLE 2:
Literature Search Strategy
In the review process, the following were exclusion criteria: non-English, nonpediatric, nonrecurrent/nonfunctional/nonchronic
abdominal pain, small study (sample size ≤5), no original data, letters to the editor, studies on Helicobacter pylori and study subjects not baseline healthy (e.g., sickle cell disease patients). The studies regarding H. pylori were excluded because the literature regarding H. pylori had been reviewed recently by a North American Society for Pediatric Gastroenterology, Hepatology and Nutrition committee and practice guidelines had been published ( ). All titles were reviewed by a single reader (HPL); 10% of the excluded articles were reviewed by two committee members (CDL, RBC), with 100% agreement regarding exclusion criteria. Of nonrejected titles, abstracts were read by a single reader (HPL) and further exclusions were made. Articles were read by at least two readers (medical student and HPL). Ten articles were abstracted in parallel, with similar results, demonstrating a reliable procedure. Data were abstracted regarding the study as a whole, design and quality, patient groups and outcomes and their values. Efforts were made to standardize the vocabulary used in recording the methodology and results, resulting in a controlled vocabulary of 1262 terms. After review, 94 articles were included in the evidence review. 11
The definitions of the study designs were as follows: uncontrolled experiment-unspecified group of participants received intervention and follow-up data were provided; case series cross section-data provided on a single group of participants; case series follow-up-baseline and follow-up data provided on a single group of participants; cohort cross section-a single group of participants were divided into two or more groups on the basis of a specified feature (e.g., history or laboratory tests) and described; cohort follow-up-baseline and follow-up data provided on a single group of participants who were divided into two or more groups; case-control-two or more groups were assembled and retrospective or current data are provided; and RCT-participants were randomly assigned to intervention and follow-up data are provided. Because the questions were all comparative, only studies with two arms or more were included in this review (thereby excluding case series).
Table 3 shows the type of articles and studies as processed in the review. Most articles were rejected on the basis of title review. Some articles were rejected at more than one point in the process, as indicated by the overlaps. Ninety-four articles were left for review. Sixty-four articles had full data investigation, which included separating articles into one or more studies in case of, for example, a baseline case-control study with a cohort follow-up; hence, the 64 articles translated into 83 studies. TABLE 3:
Articles and Studies Processed in the Review
An article might include more than one study if, for instance, there was an initial cohort cross-section with a subsequent cohort follow-up reported in the same article. Of the 83 studies for which methodology was reviewed, 46 were case-control, 20 were cohort cross section, 10 were cohort follow-up and seven were RCTs. A recent systematic review of treatments in recurrent
abdominal pain identified the same RCTs ( ), providing validation for our approach. 12
Data abstracted for each study as a whole included study city, study country, single or multiple site, site type (community, physician office, academic pediatric setting or gastroenterologist office), funding source, age range, mean and standard deviation, sample size, number of groups, number of outcomes and number of time points.
A methodology review was performed for each study on the basis of the Newcastle-Ottawa Scale for assessing the quality of nonrandomized studies in meta-analyses (
). Inclusion and exclusion criteria were noted using the controlled vocabulary. The evidence was characterized in terms of outcome type (based on the controlled vocabulary), outcome name (specific to this study), outcome units (for continuous outcomes), outcome time point (baseline or later), method (how outcome was assessed), sample size at outset and sample size at termination (a difference from sample size at outset indicated loss to follow-up). Data for continuous outcomes (in which a quantity was measured within a participant) were usually characterized by the mean and standard deviation. For categorical data (in which participants were counted once), the category was labeled using the controlled vocabulary, test statistic name, 13 P value (and comments) and data source (page/figure/table). Figure 1 summarizes the geographic distribution of the studies for which the country was provided. Of 89 articles for which data were provided, 62 (70%) were performed at a single site, 30 (34%) were based on research at an academic pediatric center, 27 (31%) were performed at a gastroenterology clinic, 17 (19%) were performed at the community level and nine (10%) were performed at general pediatric offices. Fig 1:
Geographic distribution of articles. Map courtesy
We calculated a quality score for each study as the ratio of quality items attained to the total number of items. The average, standard deviation and confidence intervals are given for each design in
Table 4. Although the quality scores seem to increase for the more preferred designs, the confidence intervals all overlap. TABLE 4:
Quality Scores by Design
Evidence tables for each of the eight questions were generated across studies and grouped according to arm type, method, or outcome, as pertinent to the question. There were 685 outcomes across the studies, categorized as history outcomes (550, 80%), tissue/physiologic outcomes (115, 17%), physical examination outcomes (15, 2%) and use of medications (5, 1%). Among the 685 outcomes, 161 of the
P values (23%) were not statistically significant, and an additional 316 (46%) were not provided by investigators. Each subcommittee member took responsibility for one or more questions. Each reviewed the evidence tables and the primary articles and generated a summary of the research. The scale for rating evidence is given in Table 5. TABLE 5:
Rating of Evidence Quality
The reviews were discussed by the subcommittee, and the Nominal Group Technique (
) was used to achieve consensus. 10 QUESTIONS
1. Is There Evidence that Children with Chronic
Abdominal Pain have Symptom Patterns that can be Categorized as Functional Dyspepsia, IBS, or Abdominal Migraine?
There is limited but credible evidence of the existence of functional dyspepsia, IBS and abdominal migraine in children (evidence quality C).
Although often discussed as a homogeneous group of patients, there are different phenotypic manifestations of functional
abdominal pain. The wide variety of descriptive terms applied to these patients' symptoms, including irritable bowel of childhood, spastic colon of childhood, nonorganic recurrent abdominal pain and psychogenic recurrent abdominal pain, reflects both the heterogeneity of the group and the limited understanding of the pathogenesis of symptoms.
The sensitivity and specificity of the Apley and Naish criteria have been questioned, and some investigators have proposed the “Rome” criteria (
), which suggest that many children and adolescents with recurrent or chronic 14 abdominal pain manifest symptom clusters that facilitate the diagnosis of disorders on the basis of symptoms alone. In 1999, a group of investigators (Rome II committee) was charged with identifying and then developing diagnostic criteria for childhood functional disorders including recurrent abdominal pain. They developed a symptom-based classification of functional disorders associated with abdominal pain ( Table 6). The goal for these criteria was to decrease cost and suffering for the patients by encouraging a defined-criteria diagnosis of the disorder rather than one obtained after excluding organic diseases. The group felt that the classic Apley and Naish criteria of recurrent abdominal pain were too general and failed to recognize that recurrent abdominal pain was not a final diagnosis. It was also apparent to the group that children and adolescents often displayed a symptom complex similar to previously described functional disorders in adults, such as IBS and functional dyspepsia. Clinical experience also suggested that a symptom complex called abdominal migraine existed. TABLE 6:
Rome II Criteria for
Functional Bowel Disorders Associated With Abdominal Pain or Discomfort in Children
A prospective study of 257 children 5 years or older presenting with
abdominal pain or discomfort, nausea or vomiting for 1 month or more identified 127 subjects meeting the Rome II criteria for dyspepsia (before evaluation for disease) ( ). Symptoms were ulcer-like in 26% and 15 dyspepsia-like in 15% of subjects. Fifty-six of these subjects underwent esophagogastroduodenoscopy and 35 were found to have no evidence of disease. These 35 subjects were believed to fulfill strict criteria for functional dyspepsia. Symptoms of IBS were present in approximately one fourth of patients with functional dyspepsia.
Questionnaires administered during a population-based study of middle school and high school students revealed a symptom complex consistent with IBS in 6% of middle-school students and 14% of high-school students (
). None of these subjects were tested for organic disease. A prospective study of 227 children 5 years or older referred to a pediatric gastroenterology clinic for evaluation of chronic 2 abdominal pain showed that 117 had symptoms consistent with IBS ( ). Diagnostic testing failed to reveal underlying disease. Concomitant upper abdominal discomfort or nausea was present in one third of these subjects. 16
A well-designed and implemented epidemiologic study (
) of a general population demonstrated an increased prevalence of a lifetime maternal history of migraine in children with recurrent 17 abdominal pain, migraine headache and abdominal migraine. Abdominal migraine was defined as recurrent abdominal pain associated with nausea or vomiting of sufficient severity to stop normal activity plus three of the following: pallor, fever, limb pain, dizziness or headache. Among study patients, 2.4% had abdominal migraine. Children with abdominal migraine were 2.6 times more likely to have a maternal history of migraine. Another prospective cross-sectional questionnaire study ( ) of a large random sample of school children 5 to 15 years old compared children with migraine headaches and children with abdominal migraine. Abdominal migraine was defined as follows: 1) pain severe enough to interfere with normal daily activities; 2) pain dull or colicky in nature; 3) periumbilical or poorly localized pain; 4) any two of anorexia, nausea, vomiting or pallor; 5) attacks lasting for at least 1 hour; and 6) complete resolution of symptoms between attacks. Approximately 4.1% had abdominal migraine. Children with migraine headaches were twice as likely to have abdominal migraine and children with abdominal migraine were twice as likely to have migraine headaches as the general population. 18 2. What is the Predictive Value of History Items?
There are no studies of unselected patients showing that pain frequency, severity, location or effects on lifestyle are able to distinguish between functional and organic disorders (evidence quality C).
Children with recurrent abdominal pain are more likely than children without recurrent abdominal pain to have headache, joint pain, anorexia, vomiting, nausea, excessive gas and altered bowel symptoms. There are insufficient data to determine whether the presence of associated symptoms can help the physician distinguish between functional and organic disorders (evidence quality C).
The presence of alarm symptoms or signs suggests a higher pretest probability or prevalence of organic disease and may justify the performance of diagnostic tests. Alarm symptoms or signs include, but are not limited to, involuntary weight loss, deceleration of linear growth, gastrointestinal blood loss, significant vomiting, chronic severe diarrhea, persistent right upper or right lower quadrant pain, unexplained fever and family history of inflammatory bowel disease (evidence quality D).
abdominal pain lacks a diagnostic marker. Because no prospective studies on natural history or incidence compare the history of children with and without recurrent episodes of abdominal pain, it cannot be stated that duration of pain itself supports a diagnosis of functional pain. The committee was able to identify 25 peer-reviewed studies of patients with chronic abdominal pain of greater than 3 months' duration in which symptom description was included in the results and patient selection criteria were most likely to exclude author bias (survey, questionnaire or consecutive patients prospectively or retrospectively enrolled for study) ( ). One quarter of these studies were performed in North America, one quarter were performed in the Far East and half were performed in Europe. The available studies provide evidence that frequency, severity, location and timing (postprandial, waking during night) of 2,8,19-41 abdominal pain do not help distinguish between organic and functional abdominal pain. Children with recurrent episodes of abdominal pain are more likely than children without abdominal pain or children with behavior disorders to have anorexia, nausea, episodic vomiting, constipation, diarrhea, headache, arthralgia or eye problems. Yet none of these associated symptoms have been reported to help distinguish between organic and functional abdominal pain. Younger age of onset of pain and inability to attend school because of pain were associated with a decision to consult a physician ( ). 37
Physical examination of children with recurrent or chronic
abdominal pain has rarely been described. The presence of tenderness on abdominal palpation has been reported to be characteristic of children with recurrent episodes of abdominal pain without evidence of organic disease when compared with control children ( ). 28 3. What is the Predictive Value of Laboratory Tests?
There is no evidence to evaluate the predictive value of blood tests (evidence quality D).
There is no evidence to determine the predictive value of blood tests in the face of alarm signals (evidence quality D).
Because researchers have used results of laboratory testing as inclusion or exclusion criteria for functional
abdominal pain, there are no studies that have evaluated the usefulness of common laboratory tests (complete blood cell count, erythrocyte sedimentation rate, comprehensive metabolic panel, urinalysis, stool parasite analysis) to distinguish between organic and functional abdominal pain. Investigations of specific biologic markers have described significant differences between patients with recurrent episodes of abdominal pain and control subjects (such as increased plasma cholecystokinin concentrations and decreased plasma oxytocin and cortisol concentrations in children with pain) ( ). However, the number of patients in these studies is small and the value of such measurements to clinical practice remains to be determined. The coexistence of 29,42 abdominal pain and an abnormal test result for a common gastrointestinal disorder, such as lactose malabsorption or H. pylori infection, does not necessarily indicate a causal relationship between the two. Treatment of lactose malabsorption often does not result in resolution of abdominal pain, and children with H. pylori infection are not more likely to have abdominal pain than children without H. pylori. Children with lactose malabsorption may have a phenotype overlapping with diarrhea-predominant IBS. 4. What are the Predictive Values of Other Diagnostic Tests?
There is no evidence to suggest that the use of ultrasonographic examination of the abdomen and pelvis in the absence of alarm symptoms has a significant yield of organic disease (evidence quality C).
There is little evidence to suggest that the use of endoscopy and biopsy in the absence of alarm symptoms has a significant yield of organic disease (evidence quality C).
There is insufficient evidence to suggest that the use of esophageal pH monitoring in the absence of alarm symptoms has a significant yield of organic disease (evidence quality C).
Ultrasonographic examination of the abdomen and pelvis is a painless, noninvasive and inexpensive test that can detect abnormalities of the kidneys, gallbladder, liver, pancreas, appendix, intestines, ovaries and uterus. When abdominal and pelvic ultrasonography has been performed in children with recurrent episodes of
abdominal pain without alarm symptoms, abnormalities have been found in fewer than 1% ( ). Abnormalities detected on ultrasonography may not be causally related to the patient's 43 abdominal pain. When atypical symptoms are present, such as jaundice, urinary symptoms, back or flank pain, vomiting or abnormal findings on physical examination, an abdominal and pelvic ultrasonography is more likely to detect an abnormality (approximately 10%).
Endoscopy and biopsy of the esophagus, stomach and duodenum, an invasive and expensive procedure, can detect esophagitis, gastritis, duodenitis and ulceration. Esophageal pH monitoring, also an invasive and expensive test, measures the frequency and duration of exposure of the esophagus to gastric acid as a means of diagnosing gastroesophageal reflux. Studies of endoscopy, biopsy or esophageal pH monitoring performed in children with recurrent
abdominal pain have demonstrated abnormalities in 25% to 56%, but reports have been limited by small sample size, sample bias, variability of findings and questionable specificity and generalizability ( ). Endoscopic or histopathologic abnormalities, such as esophagitis, gastritis or duodenitis, do not predict the prognosis, which is generally favorable in children with recurrent 40,44-46 abdominal pain, including dyspepsia ( ). 15 5. What is the Diagnostic Value of the Psychosocial History?
The literature was reviewed with respect to three domains of psychosocial history: life event
stress, child emotional/behavioral symptoms and family functioning. Life Event
There is a small amount of evidence suggesting that the presence of recent negative life events is not useful in distinguishing between functional abdominal pain and abdominal pain of other causes (evidence quality B). There is limited evidence suggesting that daily stressors are associated with the occurrence of pain episodes and that higher levels of negative life events are associated with increased likelihood of symptom persistence (evidence quality C). There is no evidence on whether life stress influences symptom severity, course or response to treatment (evidence quality D).
Studies including comparison groups of other patients are relevant in assessing the value of the psychosocial history in the differential diagnosis of chronic
abdominal pain. One study ( ) compared 30 pediatric patients with recurrent episodes of 47 abdominal pain with 30 patients referred for acute minor illness or injury. Life event change in the previous year did not differ significantly between the two groups. Another study found no difference between patients with recurrent abdominal pain and patients with minor organic disease (e.g., gastritis, esophagitis) on measures of patients' personal life events or mothers' reports of family life events ( ). No studies have found that the presence of life event 48 stress significantly differentiates patients with functional abdominal pain from other patient groups.
Nonetheless, several investigations have reported higher levels of life
stress in children with chronic abdominal pain compared with children without abdominal pain. Two studies compared pediatric patients with abdominal pain with healthy school children and found significantly higher levels of life event stress in patients with pain ( ). A diary study found that patients with recurrent episodes of 23,49 abdominal pain reported significantly more daily stressors than healthy school children, and moreover, the relation between daily stressors and somatic complaints was significantly stronger for patients with abdominal pain than for healthy school children ( ). Thus, although there is no evidence that life 41 stress helps distinguish between patients with functional abdominal pain and patients with organic disease, children with functional abdominal pain may experience stressors that warrant attention. Additional research is needed to evaluate whether these stressors contribute to symptom severity, course or response to treatment. Emotional/Behavioral Symptoms
There is evidence suggesting that the presence of anxiety, depression or behavior problems is not useful in distinguishing between functional abdominal pain and abdominal pain of other causes (evidence quality B). There is evidence that patients with recurrent abdominal pain have more symptoms of anxiety and depression (internalizing emotional symptoms) than do healthy community controls (evidence quality B). In contrast, there is evidence that children with recurrent abdominal pain do not have higher levels of conduct disorder and oppositional behavior (externalizing emotional symptoms) compared with healthy community controls (evidence quality B). There are no data on whether emotional/behavioral symptoms predict symptom severity, course or response to treatment (evidence quality D). There is evidence suggesting that children with recurrent abdominal pain are at risk of later emotional symptoms and psychiatric disorders (evidence quality B).
Several studies have used standardized measures to assess emotional/behavioral symptoms in patients with chronic
abdominal pain and other patient groups. In a study comparing 30 patients with abdominal pain with 30 patients with acute minor illness or injury, no significant differences were found between the patient groups when depression was assessed by interview or by a child self-report measure ( ). Another study comparing 19 patients with functional 47 abdominal pain with 19 patients with an organic etiology of abdominal pain found no significant differences between the groups on the Child Behavior Checklist completed by the mother or on the Rutter B2 Behavioural Scale completed by the teacher ( ). Similarly, no significant differences were found between patients with and without organic findings in two studies that included pediatric patients whose 50 abdominal pain ranged in duration from 1 month to several years ( ). Thus, no studies have found a significant difference between patients with 48,51 abdominal pain that is functional or organic in etiology with respect to emotional/behavioral symptoms.
Considerable evidence suggests that patients with chronic
abdominal pain have more symptoms of anxiety and depression than do community controls. In a study of 31 children with recurrent abdominal pain and 31 matched classroom control children, mothers' reports indicated significantly higher scores for internalizing emotional symptoms ( anxiety, depression) in children with abdominal pain ( ). Teachers' reports did not show significant group differences. However, a structured diagnostic interview indicated that 26 of the 31 children with 52 abdominal pain met the criteria for a psychiatric diagnosis. In most cases, these diagnoses were anxiety related. Others also have observed higher levels of anxiety and depression in patients with recurrent episodes of abdominal pain compared with community controls ( ), although one study found that patients with 48,51 abdominal pain were within the normal range for anxiety and depression on the basis of published normative data ( ), and another found no difference between patients with 53 abdominal pain and controls on self-report or interview measures of depression ( ). A community-based study of students in middle and high school found that those with IBS-like symptoms had significantly higher scores than their peers without IBS on self-report questionnaire measures of 25 anxiety and depression ( ). In contrast to the positive findings for 2 anxiety and depression, no studies have found significant differences between children with recurrent episodes of abdominal pain and community controls on measures of conduct disorder or oppositional behavior.
Finally, results of three studies suggest that children with recurrent
abdominal pain may be at risk of later anxiety and depression. A recent study compared 28 young adults evaluated for functional abdominal pain between the ages of 6 and 17 years with 28 matched former childhood participants of a study of tonsillectomy and adenoidectomy (controls) ( ). An average of 11 years after the target visit, a structured psychiatric diagnostic interview was administered to identify psychiatric disorders based on 7 Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) ( ) criteria. Compared with controls, those with persistent 54 abdominal pain were significantly more likely to meet criteria for a lifetime or current history of anxiety disorder. In another study, children with abdominal pain and controls were identified in data from a national longitudinal birth cohort study ( ). At 36 years of age, participants were administered a semistructured psychiatric interview that generated scores representing thresholds for psychiatric disorder. Persistent 34 abdominal pain in childhood was significantly associated with psychiatric disorder in adulthood. In a prospective study of 31 patients with recurrent abdominal pain and 31 control children, mothers' reports of depressive symptoms and anxiety in their children 5 years after baseline assessment were significantly higher for abdominal pain patients than for control children ( ). 55 Family Functioning
There is evidence that parents of patients with recurrent abdominal pain have more symptoms of anxiety, depression and somatization than do parents of community controls or parents of other pediatric patients (evidence quality C). There is some evidence that families of patients with recurrent abdominal pain do not differ from families of control children or families of patients with acute illness in broad areas of family functioning, such as family cohesion, conflict and marital satisfaction (evidence quality C).
Two studies have used structured diagnostic interviews to assess family history of psychiatric disorders in patients with recurrent episodes of
abdominal pain compared with other patient groups. In one study, 28 adults with a childhood history of recurrent episodes of abdominal pain were compared with 28 adults who had undergone minor surgery as children (controls) ( ). Participants with a history of childhood 7 abdominal pain were significantly more likely than controls to report having a first-degree relative with generalized anxiety disorder, and there was a trend suggesting group differences on family history of major depression. In another study, on the basis of interviews with 20 mothers of children with functional abdominal pain and 20 mothers of children with an organic etiology for abdominal pain, the mean number of psychiatric disorders per relative was found to be significantly higher in the functional pain group than in the organic pain group ( ). With respect to particular types of disorders, a significant difference was found only for somatization disorder, with the functional group having a higher proportion of affected relatives. A third study ( 56 ) found that compared with control parents, mothers (but not fathers) of children with recurrent episodes of 51 abdominal pain had significantly higher levels of anxiety, depression and somatization symptoms. Studies also have reported higher levels of emotional distress in parents of children with recurrent episodes of abdominal pain compared with parents of children without abdominal pain ( ). 24,25,34
Finally, a few studies have examined broad areas of family functioning. These studies have found no difference between patients with
abdominal pain and other patient groups or controls on measures of parent marital satisfaction ( ) or family cohesion and conflict ( 47,48 ). In one study, children with recurrent episodes of 48 abdominal pain reported greater parental encouragement of illness behavior than did children without abdominal pain ( ). 48 6. What is the Effectiveness of Pharmacologic Treatment?
A thorough review of the literature with a focus on RCTs revealed a paucity of studies examining pharmacologic and dietary interventions. Therefore, definitive statements concerning therapeutic efficacy are quite limited.
There is evidence that treatment for 2 weeks with peppermint oil may provide benefit in children with IBS (evidence quality B).
In a randomized, double-blind, controlled trial, 42 children with IBS were given pH-dependent, enteric-coated peppermint oil capsules or placebo. After 2 weeks, 75% of those receiving peppermint oil had decreased severity of pain associated with IBS (
). It was concluded that peppermint oil can be used as a therapeutic agent during the symptomatic phase of IBS. This was a short study of an agent not commonly used in the treatment of IBS. Entry criteria were not well described, other symptoms were not affected, and the safety and palatability of the drug were not described. Despite these shortcomings, the study represents an important proof-of-concept study supporting a beneficial effect of a medication with possible smooth muscle-relaxing properties in children with IBS. 57
There is inconclusive evidence of the benefit of H 2-receptor antagonists to treat children with dyspepsia (evidence quality B).
A double-blind, placebo-controlled trial of famotidine was conducted in 25 children with
abdominal pain and dyspepsia ( ). Among the different variables evaluated, only the global evaluation suggested that there was a benefit of famotidine over placebo. Using the quantitative assessment, however, the mean improvement of the score using famotidine versus placebo was not statistically significant. There was also a significant improvement in symptoms during the first treatment period regardless of the medication used. A subset of patients with dyspeptic symptoms demonstrated a significant benefit from the drug. In this study, enrolled children had to meet Apley and Naish criteria and had to have dyspeptic symptoms. The study population was heterogeneous, with some patients having positive 58 H. pylori titers and others having an abnormal lactose breath hydrogen test. It is the opinion of the subcommittee that H 2-receptor antagonists may be beneficial for children with severe dyspeptic symptoms (including heartburn), but the results were difficult to generalize to children with functional abdominal pain.
There is inconclusive evidence that fiber supplement intake decreases the frequency of pain attacks for patients with recurrent abdominal pain (evidence quality B).
A randomized, double-blind, placebo-controlled study in 52 children with recurrent episodes of
abdominal pain recruited from primary care practices ( ) demonstrated a statistically significant decrease in pain attacks in children who were given additional fiber, compared with those receiving placebo. The study involved small groups (26 each), and improvement was marginal (seven improved with placebo and 13 with fibers). 59
There is inconclusive evidence that a lactose-free diet decreases symptoms in children with recurrent abdominal pain (evidence quality B).
In a study of 103 children 6 to 14 years of age with nonlocalized
abdominal pain for 4 months, a similar prevalence of lactase deficiency was found in the control and abdominal pain groups ( ). Thirty-eight patients completed three successive 6-week diet trials conducted in a double-blind fashion. The patients were then placed on a 12-month milk elimination diet. The results suggested that the elimination of lactose did not affect the overall rate of improvement in 60 abdominal pain. In addition, the recovery rate was similar in both lactose absorbers and nonabsorbers, independent of dietary restrictions. This study suggested that lactose intolerance and recurrent abdominal pain are two separate entities, and a lactose-free diet has no effect on outcome of abdominal pain in lactose absorbers and nonabsorbers.
There are limited data to suggest that pizotifen is efficacious in the treatment of abdominal migraine (evidence quality B).
Pizotifen is a potent antagonist of the 5-HT2A receptor that is not approved for use in the United States. A placebo-controlled crossover study used pizotifen for the treatment of 14 children with abdominal migraine (
). Patients received either pizotifen (0.25 mg, twice daily) or placebo syrup for 2 months, then the alternate treatment for 2 months. While being treated with pizotifen, the study children had fewer days of 61 abdominal pain and lower indices of severity and misery. The medication was well tolerated. These results may not be generalizable to children with milder symptoms. Common adverse effects include drowsiness, dizziness, increased appetite and weight gain. 7. What is the Effectiveness of Cognitive-Behavioral Therapy?
There is evidence that cognitive-behavioral therapy may be useful in improving pain and disability outcome in the short term (evidence quality B).
Two RCTs (
) evaluated the efficacy of a cognitive-behavioral program and a cognitive-behavioral family intervention for the treatment of nonspecific 62,63 abdominal pain. In the first study, results showed that both the experimental and the control groups had decreased levels of pain. However, the treated group improved more quickly, the effects generalized to the school setting, and a larger proportion of subjects were completely pain-free by 3-month follow-up. In the second study, the children and mothers who were taught coping skills had a higher rate of complete elimination of pain, lower levels of relapse at 6 and 12 months' follow-up and lower levels of interference with their activities as a result of pain, and parents reported a higher level of satisfaction with the treatment. After controlling for pretreatment levels of pain, children's active self-coping and mothers' caregiving strategies were significant independent predictors of pain behavior after treatment. 8. What is the Effectiveness of Surgery?
There is no evidence of the possible beneficial role of surgery in the evaluation or management of children with recurrent abdominal pain (evidence quality D).
There are no studies comparing diagnostic or therapeutic surgery with other approaches (evidence quality D).
The literature search identified a study (
) aimed at evaluating the results of diagnostic laparoscopy in children with chronic recurrent 64 abdominal pain. It was a series of 13 children with chronic severe episodes of abdominal pain who were subjected to diagnostic laparoscopy. Extensive laboratory and imaging studies did not contribute to the diagnosis. Laparoscopic findings that identified the cause of abdominal pain were obtained in 12 of 13 patients. Laparoscopic appendectomy was performed in all patients. Follow-up varied from 6 months to 3 years. Abdominal pain resolved in 10 patients. It was concluded that diagnostic laparoscopy is a valuable procedure in the management of children with chronic recurrent abdominal pain. The study patients represented a subgroup of children with very severe symptoms of abdominal pain, all having required hospitalization and multiple imaging studies. Although they were all found to have an organic etiology for their pain, some of the etiologies may actually be debatable as causes of disease-for example, cecal adhesion or fibrosed appendix. Two patients required another laparoscopy for complications related to the first one. No other study addresses laparoscopy or other procedures as treatments of recurrent abdominal pain. SUMMARY
abdominal pain (long-standing intermittent or constant abdominal pain) is common in children and adolescents. In most children, chronic abdominal pain is functional-that is, without objective evidence of an underlying organic disorder. Yet an important part of the physician's job is to determine which children have an organic disorder. A review of the current evidence, however, indicates that there are no studies showing that pain frequency, severity, location or effects on lifestyle help to discriminate between functional and organic disorders. Children with chronic abdominal pain are more likely than children without chronic abdominal pain to have headache, joint pain, anorexia, vomiting, nausea, excessive gas and altered bowel symptoms, but there is insufficient evidence that the presence of the associated symptoms can help the physician discriminate between functional and organic disorders. Although children with chronic abdominal pain and their parents are more often anxious or depressed, the presence of anxiety, depression, behavior problems or recent negative life events does not appear to be useful in distinguishing between functional and organic abdominal pain.
There is evidence that children with functional
abdominal pain can have symptom clusters characterized as functional dyspepsia, IBS or abdominal migraine as well as isolated abdominal pain. Some patients have features of more than one type of functional abdominal pain.
The physician must also decide whether to order diagnostic tests and, if so, which tests. The presence of alarm symptoms or signs suggests a higher pretest probability or prevalence of organic disease and may justify the performance of diagnostic tests. Alarm symptoms or signs include, but are not limited to, weight loss, deceleration of linear growth velocity, significant vomiting, chronic severe diarrhea, evidence of gastrointestinal blood loss, persistent right upper or right lower quadrant pain, unexplained fever, family history of inflammatory bowel disease or abnormal or unexplained physical findings. The predictive value of blood tests, with or without alarm signals, has not been adequately studied. There is no evidence to suggest that the use of ultrasonographic examination of the abdomen and pelvis in the absence of alarm symptoms has a significant yield of organic disease. There is little evidence to suggest that the use of endoscopy with biopsy or esophageal pH monitoring has a significant yield of organic disease in the absence of alarm symptoms.
There is limited evidence suggesting that daily stressors are associated with the occurrence of pain episodes and that higher levels of negative life events are associated with increased likelihood of symptom persistence. Some evidence suggests that patients with chronic
abdominal pain have more symptoms of anxiety and depression than do community controls and are at greater risk of later emotional symptoms and psychiatric disorders. However, there are no data on whether emotional or behavioral symptoms predict symptom severity, course or response to treatment. Parents of patients with chronic abdominal pain appear to have more symptoms of anxiety, depression and somatization than do parents of community controls or parents of other pediatric patients. However, families of children with chronic abdominal pain do not appear to differ from families of children without abdominal pain or families of patients with acute illness in broad areas of family functioning.
There have been few studies of the treatment of chronic
abdominal pain in children. There is inconclusive evidence that a lactose-free diet decreases symptoms or that a fiber supplement decreases the frequency of pain attacks. There is inconclusive evidence of the benefit of acid suppression with H 2-receptor antagonists to treat children with dyspepsia. There is evidence that treatment for 2 weeks with peppermint oil may provide benefit in children with IBS. There is also evidence that cognitive/behavioral therapy may be useful in improving pain and disability outcome in the short term.
Carlo Di Lorenzo, M.D., AUTHOR
Richard B. Colletti, M.D., AUTHOR
Horald P. Lehmann, M.D., Ph.D., AUTHOR
John T. Boyle, M.D., AUTHOR
South Birmingham, A.L.
William T. Gerson, M.D., AUTHOR
Jeffrey S. Hyams, M.D., AUTHOR
Robert H. Squires, Jr., M.D., AUTHOR
Lynn S. Walker, Ph.D., AUTHOR
Pamela T. Kanda, M.P.H., STAFF
1. Starfield B, Hoekelman R, Mc Cormick M, et al. Who provides health care to children and adolescents in the United States?
2. Hyams JS, Burke G, Davis PM, Rzepski B, Andrulonis PA.
irritable bowel syndrome
in adolescents: a community-based study.
3. Frank L, Kleinman L, Rentz A, Ciesla G, Kim JJ, Zacker C. Health-related quality of life associated with
irritable bowel syndrome
: comparison with other chronic diseases.
4. Drossman DA, Li Z, Andruzzi E, et al. U.S. householder survey of functional gastrointestinal disorders: prevalence, sociodemography, and health impact.
Dig Dis Sci
5. Talley NJ, Gabriel SE, Harmsen WS, Zinsmeister AR, Evans RW. Medical costs in community subjects with
irritable bowel syndrome
6. Martin R, Barron JJ, Zacker C.
Irritable bowel syndrome
: toward a cost-effective management approach.
Am J Manag Care
7. Campo JV, Di Lorenzo C, Chiappetta L, et al. Adult outcomes of pediatric recurrent
: do they just grow out of it?
2001;108. Available at:
8. Apley J, Naish N. Recurrent abdominal pains: a field survey of 1,000 school children.
Arch Dis Child
9. Woolf SH.
AHCPR Interim Manual for Clinical Practice Guideline Development
. Rockville, MD: US Department of Health and Human Services; 1991.
10. Jones J, Hunter D. Consensus methods for medical and health services research.
11. Gold BD, Colletti RB, Abbott M, et al.
infection in children: recommendations for diagnosis and treatment.
J Pediatr Gastroenterol Nutr
12. Weydert JA, Ball TM, Davis MF. Systematic review of treatments for recurrent
2003;111. Available at:
13. Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-analyses. Ottawa, Ontario: Ottawa Health Research Institute, University of Ottawa. Available at:
. Accessed April 15, 2004.
14. Rasquin-Weber A, Hyman PE, Cucchiara S, et al. Childhood functional gastrointestinal disorders.
1999;45 Suppl 2:II60-8.
15. Hyams JS, Davis P, Sylvester FA, Zeiter DK, Justinich CJ, Lerer T.
in children and adolescents: a prospective study.
J Pediatr Gastroenterol Nutr
16. Hyams JS. Recurrent
irritable bowel syndrome
J Pediatr Gastroenterol Nutr
1997;25 Suppl 1:S16-7.
17. Mortimer MJ, Kay J, Jaron A, Good PA. Does a history of maternal migraine or
predispose children to headache and stomach-ache?
18. Abu-Arafeh I, Russell G. Prevalence and clinical features of abdominal migraine compared with those of migraine headache.
Arch Dis Child
19. Turner RM. Recurrent
J R Coll Gen Pract
20. Barr RG, Levine MD, Watkins JB. Recurrent
of childhood due to lactose intolerance.
N Engl J Med
21. Bhan MK, Arora NK, Ghai OP, Dhamija NK, Nayyar S, Fotedar A. Lactose and milk intolerance in recurrent
Indian J Pediatr
22. Wald A, Chandra R, Fisher SE, Gartner JC, Zitelli B. Lactose malabsorption in recurrent
23. Hodges K, Kline JJ, Barbero G, Flanery R. Life events occurring in families of children with recurrent
J Psychosom Res
24. Hodges K, Kline JJ, Barbero G, Woodruff C.
in children with recurrent
and their parents.
25. Hodges K, Kline JJ, Barbero G, Flanery R. Depressive symptoms in children with recurrent
and in their families.
26. Ceriani R, Zuccato E, Fontana M, et al. Lactose malabsorption and recurrent
in Italian children.
J Pediatr Gastroenterol Nutr
27. Alfven G. The covariation of common psychosomatic symptoms among children from socio-economically differing residential areas: an epidemiologic study.
28. Alfven G. The pressure pain threshold (PPT) of certain muscles in children suffering from recurrent
of non-organic origin: an algometric study.
29. Alfven G, de la Torre B, Uvnas-Moberg K. Depressed concentrations of oxytocin and cortisol in children with recurrent
of non-organic origin.
30. Ashorn M, Maki M, Ruuska T, et al. Upper gastrointestinal endoscopy in recurrent
J Pediatr Gastroenterol Nutr
31. Mortimer MJ, Kay J, Jaron A. Clinical epidemiology of childhood abdominal migraine in an urban general practice.
Dev Med Child Neurol
32. Christensen MF. Motilin in children with recurrent
: a controlled study.
33. Abu-Arafeh I, Russell G. Paroxysmal vertigo as a migraine equivalent in children: a population-based study.
34. Hotopf M, Carr S, Mayou R, Wadsworth M, Wessely S. Why do children have chronic
, and what happens to them when they grow up? Population based cohort study.
35. Boey CC, Yap SB. An epidemiologic survey of recurrent
in a rural Malay school.
J Paediatr Child Health
36. Boey C, Yap S, Goh KL. The prevalence of recurrent
in 11- to 16-year-old Malaysian schoolchildren.
J Paediatr Child Health
37. Boey CC, Goh KL. Recurrent
and consulting behaviour among children in a rural community in Malaysia.
Dig Liver Dis
38. Boey CC, Goh KL. Stressful life events and recurrent
in children in a rural district in Malaysia.
Eur J Gastroenterol Hepatol
39. Boey CC, Goh KL. Predictors of health-care consultation for recurrent
among urban schoolchildren in Malaysia.
J Gastroenterol Hepatol
40. Kokkonen J, Ruuska T, Karttunen TJ, Niinimaki A. Mucosal pathology of the foregut associated with food allergy and recurrent abdominal pains in children.
41. Walker LS, Garber J, Smith CA, Van Slyke DA, Claar RL. The relation of daily stressors to somatic and emotional symptoms in children with and without recurrent
J Consult Clin Psychol
42. Alfven G, Uvnas-Moberg K. Elevated cholecystokinin concentrations in plasma in children with recurrent
43. Yip WC, Ho TF, Yip YY, Chan KY. Value of abdominal sonography in the assessment of children with
J Clin Ultrasound
44. Quak SH, Low PS, Wong HB. Upper gastrointestinal endoscopy in children with
Ann Acad Med Singapore
45. van der Meer SB, Forget PP, Kuijten RH, Arends JW. Gastroesophageal reflux in children with recurrent
46. Soeparto P. Endoscopic examinations in children with recurrent
47. McGrath PJ, Goodman JT, Firestone P, Shipman R, Peters S. Recurrent
: a psychogenic disorder?
Arch Dis Child
48. Walker LS, Garber J, Greene JW. Psychosocial correlates of recurrent childhood pain: a comparison of pediatric patients with recurrent
, organic illness, and psychiatric disorders.
J Abnorm Psychol
49. Robinson JO, Alverez JH, Dodge JA. Life events and family history in children with recurrent
J Psychosom Res
50. Sawyer MG, Davidson GP, Goodwin D, Crettenden AD. Recurrent
in childhood. Relationship to psychologic adjustment of children and families: a preliminary study.
Aust Paediatr J
51. Walker LS, Greene JW. Children with recurrent
and their parents: more somatic complaints,
than other patient families?
J Pediatr Psychol
52. Wasserman AL, Whitington PF, Rivara FP. Psychogenic basis for
in children and adolescents.
J Am Acad Child Adolesc Psychiatry
53. Olafsdottir E, Ellertsen B, Berstad A, Fluge G. Personality profiles and heart rate variability (vagal tone) in children with recurrent
54. American Psychiatric Association.
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV)
. Washington, DC: American Psychiatric Association; 1994.
55. Walker LS, Garber J, Van Slyke DA, Greene JW. Long-term health outcomes in patients with recurrent
J Pediatr Psychol
56. Routh DK, Ernst AR. Somatization disorder in relatives of children and adolescents with functional
J Pediatr Psychol
57. Kline RM, Kline JJ, Di Palma J, Barbero GJ. Enteric-coated, pH-dependent peppermint oil capsules for the treatment of
irritable bowel syndrome
58. See MC, Birnbaum AH, Schechter CB, Goldenberg MM, Benkov KJ. Double-blind, placebo-controlled trial of famotidine in children with
: global and quantitative assessment.
Dig Dis Sci
59. Feldman W, McGrath P, Hodgson C, Ritter H, Shipman RT. The use of dietary fiber in the management of simple, childhood, idiopathic, recurrent,
. Results in a prospective, double-blind, randomized, controlled trial.
Am J Dis Child
60. Lebenthal E, Rossi TM, Nord KS, Branski D. Recurrent
and lactose absorption in children.
61. Symon DN, Russell G. Double blind placebo controlled trial of pizotifen syrup in the treatment of abdominal migraine.
Arch Dis Child
62. Sanders MR, Rebgetz M, Morrison M, et al. Cognitive-behavioral treatment of recurrent nonspecific
in children: an analysis of generalization, maintenance, and side effects.
J Consult Clin Psychol
63. Sanders MR, Shepherd RW, Cleghorn G, Woolford H. The treatment of recurrent
in children: a controlled comparison of cognitive-behavioral family intervention and standard pediatric care.
J Consult Clin Psychol
64. Stringel G, Berezin SH, Bostwick HE, Halata MS. Laparoscopy in the management of children with chronic recurrent
A Summary of the Quality of the Evidence